...
首页> 外文期刊>Journal of Medicinal Chemistry >Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether.
【24h】

Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether.

机译:第一代1,2,4-三恶烷蒿甲醚的新型,强效,半合成抗疟疾碳水化合物类似物。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ten novel, second-generation, fluorinated ether and ester analogues of the potent first-generation analogues artemether (4a) and arteether (4b) have been designed and synthesized. All of the compounds demonstrate high antimalarial potency in vitro against the chloroquine-sensitive HB3 and -resistant K1 strains of Plasmodium falciparum. The most potent derivative 8 was 15 times more potent than artemisinin (2) against the HB3 strain of P. falciparum. In vivo, versus Plasmodium berghei in the mouse, selected derivatives were generally less potent than dihydroartemisinin with ED(50) values of between 5 and 8 mg/kg. On the basis of the products obtained from the in vitro biomimetic Fe(II)-mediated decomposition of 8, the radical mediator of biological activity of this series may be different from that of the parent drug, artemisinin (2).
机译:已经设计和合成了有效的第一代类似物蒿甲醚(4a)和蒿甲醚(4b)的十个新颖的第二代氟化醚和酯类似物。所有这些化合物在体外对恶性疟原虫的氯喹敏感型HB3和耐药K1菌株均表现出很高的抗疟药效力。对于恶性疟原虫的HB3菌株,最有效的衍生物8的效力是青蒿素(2)的15倍。在体内,与小鼠伯氏疟原虫相比,所选衍生物的效力一般不如二氢青蒿素,ED(50)值在5至8 mg / kg之间。根据体外仿生Fe(II)介导的8分解产物获得的结果,该系列生物活性的自由基介体可能与母体药物青蒿素(2)不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号